{
  "id": 1485185,
  "title": "Eight biotech companies in Melbourne you should know about",
  "url": "https://urgent.news/2026/08/17/eight-biotech-companies-in-melbourne-you-should-know-about",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-17T13:15:00.000Z",
  "source": {
    "name": "Labiotech",
    "slug": "labiotech",
    "url": "https://www.labiotech.eu/best-biotech/biotech-companies-melbourne/"
  },
  "original_language": "en",
  "account": "Melbourne, located on the southeastern coast of Australia, is a thriving life science hub in the Asia Pacific region. The city houses numerous innovative biotech companies, with a 20% growth in 2020, despite the overall Asia Pacific market decline. Among the eight biotech companies featured in this article, Telix Pharmaceuticals is a leading name in radiopharmaceuticals, with its flagship product Illuccix used for prostate cancer diagnosis. The company also has an extensive clinical pipeline of radiopharmaceuticals, including TLX591-Tx for urological oncology and TLX101-Tx for glioblastoma. Ena Respiratory, another Melbourne-based biotech, focuses on prophylactics for infections with its small molecule INNA-051, which activates the innate immune system to fight viral respiratory infections. Meanwhile, Mesoblast, a cell therapy company, received FDA approval for its drug Ryoncil to treat acute graft versus host disease in children. Revascor, another cell therapy company, is developing Revascor to treat heart disease, with an FDA nod in the pipeline.",
  "summary": "Discover 8 biotech companies in Melbourne, ranging from commercial to preclinical-stage companies, advancing promising technologies. The post Eight biotech companies in Melbourne you should know about appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is…",
  "key_points": [
    "Telix Pharmaceuticals leads in radiopharmaceuticals with Illuccix for prostate cancer",
    "Ena Respiratory develops INNA-051 to combat viral respiratory infections",
    "Mesoblast receives FDA approval for Ryoncil to treat acute graft vs host disease in children"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}